Literature DB >> 10581329

International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors.

F Noble1, S A Wank, J N Crawley, J Bradwejn, K B Seroogy, M Hamon, B P Roques.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10581329

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  88 in total

1.  Identification of a series of CCK-2 receptor nonpeptide agonists: sensitivity to stereochemistry and a receptor point mutation.

Authors:  Alan S Kopin; Edward W McBride; Ci Chen; Roger M Freidinger; Duan Chen; Chun-Mei Zhao; Martin Beinborn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

2.  A sucrose-derived scaffold for multimerization of bioactive peptides.

Authors:  Venkataramanarao Rao; Ramesh Alleti; Liping Xu; Narges K Tafreshi; David L Morse; Robert J Gillies; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2011-08-27       Impact factor: 3.641

3.  The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.

Authors:  T D Barrett; G Lagaud; P Wagaman; J M Freedman; W Yan; L Andries; M C Rizzolio; M F Morton; N P Shankley
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

4.  Molecular cloning, expression and pharmacological characterization of the canine cholecystokinin 1 receptor.

Authors:  Magda Francesca Morton; Jayashree Pyati; Heng Dai; Lina Li; Veronica Moreno; Nigel Paul Shankley
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

5.  Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.

Authors:  M A Coudoré-Civiale; M Méen; M C Fournié-Zaluski; M Boucher; B P Roques; A Eschalier
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

6.  Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway.

Authors:  M Fornai; R Colucci; L Antonioli; F Crema; P Buccianti; M Chiarugi; F Baschiera; N Ghisu; M Tuccori; C Blandizzi; M Del Tacca
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

Review 7.  Gastrin: old hormone, new functions.

Authors:  Graham Dockray; Rod Dimaline; Andrea Varro
Journal:  Pflugers Arch       Date:  2004-10-05       Impact factor: 3.657

8.  Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats.

Authors:  Victoria Cano; Laura Ezquerra; M Pilar Ramos; Mariano Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

9.  Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2015-02-26       Impact factor: 3.641

10.  Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions.

Authors:  Matthew J Coleshill; Louise Sharpe; Luana Colloca; Robert Zachariae; Ben Colagiuri
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.